The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ...

NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming ...

Diabetes drug Victoza, or liraglutide, is a first generation GLP-1, a class of treatments that has seen overwhelming demand. It has been on the FDA's shortage list since 2023, and currently ...

India is developing a framework for over-the-counter (OTC) drugs, potentially allowing some prescription medications to be sold in general stores. A sub-committee is reviewing international guidelines ...

Neither drug is considered as effective as the brand ... requiring treatment for type 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run more than $1,000 a month ...